239 related articles for article (PubMed ID: 37515245)
21. The case of a liver-transplant recipient with severe acute respiratory syndrome coronavirus 2 infection who had a favorable outcome.
Hayashi K; Ito Y; Yamane R; Yoshizaki M; Matsushita K; Kajikawa G; Kozawa T; Mizutani T; Shimizu Y; Nagano K; Tachi K; Yoshioka K; Goto H
Clin J Gastroenterol; 2021 Jun; 14(3):842-845. PubMed ID: 33675512
[TBL] [Abstract][Full Text] [Related]
22. Immunocompromised Seroprevalence and Course of Illness of SARS-CoV-2 in One Pediatric Quaternary Care Center.
Freeman MC; Rapsinski GJ; Zilla ML; Wheeler SE
J Pediatric Infect Dis Soc; 2021 Apr; 10(4):426-431. PubMed ID: 33049042
[TBL] [Abstract][Full Text] [Related]
23. Risks of infection and severity of coronavirus disease 2019 in kidney transplant recipients: A single-center cohort study.
Inoue K; Hori S; Tomizawa M; Yoneda T; Nakai Y; Miyake M; Tanaka N; Fujimoto K
Transpl Immunol; 2024 Jun; 84():102023. PubMed ID: 38452985
[TBL] [Abstract][Full Text] [Related]
24. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
25. Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients.
Rabinowich L; Grupper A; Baruch R; Ben-Yehoyada M; Halperin T; Turner D; Katchman E; Levi S; Houri I; Lubezky N; Shibolet O; Katchman H
J Hepatol; 2021 Aug; 75(2):435-438. PubMed ID: 33892006
[TBL] [Abstract][Full Text] [Related]
26. COVID-19 in pediatric lung transplant recipients: Clinical course and outcome.
Schütz K; Davids J; Petrik B; Zychlinsky Scharff A; Carlens J; Heim A; Salman J; Ius F; Bobylev D; Hansen G; Müller C; Schwerk N
J Heart Lung Transplant; 2023 Apr; 42(4):533-538. PubMed ID: 36526496
[TBL] [Abstract][Full Text] [Related]
27. Clinical Features and Outcomes Following SARS-CoV-2 Infection in Pediatric Liver Transplant Patients.
Siddiqui MA; Bakirci O; Dönger U; Warasnhe K; Özçay F; Haberal M
Exp Clin Transplant; 2022 May; 20(Suppl 3):66-71. PubMed ID: 35570604
[TBL] [Abstract][Full Text] [Related]
28. Liver transplant in a recently COVID-19 positive child with hepatoblastoma.
Goss MB; Munoz FM; Ruan W; Galván NTN; O'Mahony CA; Rana A; Cotton RT; Moreno NF; Heczey AA; Leung DH; Goss JA
Pediatr Transplant; 2021 Aug; 25(5):e13880. PubMed ID: 32979013
[TBL] [Abstract][Full Text] [Related]
29. Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age.
Khan FL; Nguyen JL; Singh TG; Puzniak LA; Wiemken TL; Schrecker JP; Taitel MS; Zamparo JM; Jodar L; McLaughlin JM
JAMA Netw Open; 2022 Dec; 5(12):e2246915. PubMed ID: 36515946
[TBL] [Abstract][Full Text] [Related]
30. Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
Fleming-Dutra KE; Britton A; Shang N; Derado G; Link-Gelles R; Accorsi EK; Smith ZR; Miller J; Verani JR; Schrag SJ
JAMA; 2022 Jun; 327(22):2210-2219. PubMed ID: 35560036
[TBL] [Abstract][Full Text] [Related]
31. A comprehensive assessment of long-term SARS-CoV-2-specific adaptive immune memory in convalescent COVID-19 Solid Organ Transplant recipients.
Favà A; Donadeu L; Jouve T; Gonzalez-Costello J; Lladó L; Santana C; Toapanta N; Lopez M; Pernin V; Facundo C; Cabañas NS; Thaunat O; Crespo M; Llinàs-Mallol L; Revuelta I; Sabé N; Rombauts A; Calatayud L; Ardanuy C; Esperalba J; Fernandez C; Lozano JJ; Preyer R; Strecker K; Couceiro C; García-Romero E; Cachero A; Meneghini M; Torija A; Le Quintrec M; Melilli E; Cruzado JM; Polo C; Moreso F; Crespo E; Bestard O
Kidney Int; 2022 May; 101(5):1027-1038. PubMed ID: 35124011
[TBL] [Abstract][Full Text] [Related]
32. Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar.
Butt AA; Dargham SR; Chemaitelly H; Al Khal A; Tang P; Hasan MR; Coyle PV; Thomas AG; Borham AM; Concepcion EG; Kaleeckal AH; Latif AN; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
JAMA Intern Med; 2022 Feb; 182(2):197-205. PubMed ID: 34935861
[TBL] [Abstract][Full Text] [Related]
33. Covid-19 in liver transplant recipients: the French SOT COVID registry.
Dumortier J; Duvoux C; Roux O; Altieri M; Barraud H; Besch C; Caillard S; Coilly A; Conti F; Dharancy S; Durand F; Francoz C; Garaix F; Houssel-Debry P; Kounis I; Lassailly G; Laverdure N; Leroy V; Mallet M; Mazzola A; Meunier L; Radenne S; Richardet JP; Vanlemmens C; Hazzan M; Saliba F; ;
Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101639. PubMed ID: 33636654
[TBL] [Abstract][Full Text] [Related]
34. Outcome of COVID-19 in liver transplant recipients: A preliminary report from Northwestern Italy.
Patrono D; Lupo F; Canta F; Mazza E; Mirabella S; Corcione S; Tandoi F; De Rosa FG; Romagnoli R
Transpl Infect Dis; 2020 Oct; 22(5):e13353. PubMed ID: 32500942
[TBL] [Abstract][Full Text] [Related]
35. [Clinical features of 19 children infected with the Omicron variant of severe acute respiratory syndrome coronavirus 2 in Hangzhou, China].
Qi ZH; Bei ZF; Teng S; Wang HP; Li W; Zhao SY; Liu SR
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Oct; 24(10):1092-1097. PubMed ID: 36305108
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
[TBL] [Abstract][Full Text] [Related]
37. T cell repertoire profiling in allografts and native tissues in recipients with COVID-19 after solid organ transplantation: Insight into T cell-mediated allograft protection from viral infection.
Fu J; Rust D; Fang Z; Jiao W; Lagana S; Batal I; Chen B; Merl S; Jones R; Sykes M; Weiner J
Front Immunol; 2022; 13():1056703. PubMed ID: 36591281
[TBL] [Abstract][Full Text] [Related]
38. Multisystem inflammatory syndrome in children associated with SARS-CoV-2 in a solid organ transplant recipient.
Petters LM; Vogel TP; Munoz FM; Hernandez JA; Koohmaraie S; Nowicki MJ; Zumbro CE; Mysore KR
Am J Transplant; 2021 Jul; 21(7):2596-2599. PubMed ID: 33754452
[TBL] [Abstract][Full Text] [Related]
39. Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients.
Toniutto P; Falleti E; Cmet S; Cussigh A; Veneto L; Bitetto D; Fornasiere E; Fumolo E; Fabris C; Sartor A; Peressutti R; Curcio F; Regattin L; Grillone L
J Hepatol; 2022 Jul; 77(1):152-162. PubMed ID: 35283215
[TBL] [Abstract][Full Text] [Related]
40. Investigating Whether the Severity of SARS-CoV-2 Infection Is Higher in Liver Transplant Recipients: A Single-Center Experience.
Turan Gökçe D; Arı D; Aypak A; Aydın O; Kaçar S; Bostancı EB; Akdoğan Kayhan M
Exp Clin Transplant; 2023 Oct; 21(10):837-840. PubMed ID: 35297331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
